资讯
A novel oral peptide PN-477o with once-daily dosing, high potency and activation of glucagon-like peptide-1 (GLP-1), ...
Rezpegaldesleukin, an investigational interleukin-pathway agonist, demonstrated efficacy and safety for people with moderate ...
Icotrokinra was safe and effective for improving skin clearance among patients with at least moderate psoriasis in ...
US biotech Nektar Therapeutics experienced a remarkable 130% increase in its share price, which reached $21.9, as it reported ...
The Food and Drug Administration has approved Dupixent (dupilumab) for the treatment of adult patients with bullous pemphigoid.
3 天
MedPage Today on MSNJAK Inhibitors' Cancer Risk Confirmed in Real-World DataThe RABBIT registry is supported by a joint, unconditional grant from AbbVie, Alfasigma, Amgen, Biocon, Bristol Myers Squibb, ...
Background and aim: Interleukin (IL) 17 is a cytokine which exerts strong proinflammatory activities. In this study we evaluated changes in IL-17 expression in the inflamed mucosa and in the serum of ...
The iPhone 16e costs a lot less than the iPhone 16, but it makes some trade-offs. After testing both models, we've broken down the key changes to help you figure out which one is best for you.
The iPhone 16 and iPhone 16 Pro are sleek, powerful devices — and also serious investments. If you're lucky enough to have one in hand, the last thing you want is a drop, scratch or scuff ...
Theresa Medina, MD, associate professor of medicine-medical oncology at the University of Colorado Cancer Center, Anschutz ...
6 天
Stocktwits on MSNNektar Therapeutics Announces Positive Data From Eczema Drug In Mid-stage Trial: Stock More ...Shares of Nektar Therapeutics (NKTR) more than doubled on Tuesday afternoon after the company announced that its mid-stage ...
一些您可能无法访问的结果已被隐去。
显示无法访问的结果